Eli Lilly Strikes Up to $2.75 Billion AI Drug Deal With Insilico Medicine
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
#EliLilly
Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "eli lilly", collected in one continuously updated archive.
Related Posts
Eli Lilly Becomes First Health-Care Company to Reach $1 Trillion Market Value
Eli Lilly crossed a $1 trillion market capitalization for the first time, powered by booming demand for its diabetes and weight-loss drugs.